HomeCompareACYN vs JNJ

ACYN vs JNJ: Dividend Comparison 2026

ACYN yields 9.81% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 ACYN wins by $18.3K in total portfolio value
10 years
ACYN
ACYN
● Live price
9.81%
Share price
$20.38
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$38.3K
Annual income
$1,818.96
Full ACYN calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — ACYN vs JNJ

📍 ACYN pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodACYNJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, ACYN + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
ACYN pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ACYN
Annual income on $10K today (after 15% tax)
$834.15/yr
After 10yr DRIP, annual income (after tax)
$1,546.12/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, ACYN beats the other by $842.50/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ACYN + JNJ for your $10,000?

ACYN: 50%JNJ: 50%
100% JNJ50/50100% ACYN
Portfolio after 10yr
$29.2K
Annual income
$1,323.37/yr
Blended yield
4.54%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

ACYN
No analyst data
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ACYN buys
0
JNJ buys
0
No recent congressional trades found for ACYN or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricACYNJNJ
Forward yield9.81%3.36%
Annual dividend / share$2.00$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR0%5.8%
Portfolio after 10y$38.3K$20.0K
Annual income after 10y$1,818.96$827.78
Total dividends collected$14.0K$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: ACYN vs JNJ ($10,000, DRIP)

YearACYN PortfolioACYN Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$11,681$981.35$10,676$355.77+$1.0KACYN
2$13,570$1,071.36$11,407$389.39+$2.2KACYN
3$15,684$1,163.19$12,198$426.53+$3.5KACYN
4$18,038$1,256.37$13,056$467.62+$5.0KACYN
5$20,651$1,350.43$13,987$513.12+$6.7KACYN
6$23,541$1,444.92$14,998$563.56+$8.5KACYN
7$26,729$1,539.41$16,098$619.52+$10.6KACYN
8$30,233$1,633.49$17,295$681.69+$12.9KACYN
9$34,076$1,726.78$18,599$750.82+$15.5KACYN
10$38,280$1,818.96$20,022$827.78+$18.3KACYN

ACYN vs JNJ: Complete Analysis 2026

ACYNStock

The FT Vest Laddered Autocallable Barrier & Income ETF (the "Fund") seeks to provide investors with distributions while limiting downside market volatility. The Fund seeks to achieve its investment objective by entering into swap agreements and/or option contracts structured similarly to swap agreements that seek to deliver a return reflecting the performance of a laddered portfolio of theoretically created financial instruments designed to replicate the defined return characteristics of autocallable yield notes.

Full ACYN Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this ACYN vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ACYN vs SCHDACYN vs JEPIACYN vs OACYN vs KOACYN vs MAINACYN vs ABBVACYN vs MRKACYN vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.